Jing ZHANG - 张京

China

Research Fellow

Jing is a research fellow at the George Institute for Global Health, China and is currently working on the International Orthopedic Multicenter Study.

Jing received his Bachelor of Preventive Medicine from Capital University of Medical Science and his Master of Epidemiology and Health Statistics from China Medical University.

Jing ZHANG - 张京

Further Reading

Inaccuracy of Self-reported Low Sodium Diet among Chinese: Findings from Baseline Survey for Shandong & Ministry of Health Action on Salt and Hypertension (SMASH) Project

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I

Design of the CHina Epidemiology Research in Subarachnoid Haemorrhage (CHERISH) study

Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage

Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country

Jing ZHANG - 张京

Further Reading

Injury

Inaccuracy of Self-reported Low Sodium Diet among Chinese: Findings from Baseline Survey for Shandong & Ministry of Health Action on Salt and Hypertension (SMASH) Project

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I

Design of the CHina Epidemiology Research in Subarachnoid Haemorrhage (CHERISH) study

Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage

Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)